B. Haynes

P04-45. Characterization of the plasma cell repertoire in acute HIV-1 infection (AHI) (2009)

Liao, L, Chen, X, Dixon, A, Munshaw, S, Moody, M, Zhang, R, ...

No abstract available.

P09-21 LB. Deep sequencing of HIV-1 from acute infection: low initial diversity, and rapid but variable CTL escape (2009)

Fischer, W, Keele, B, Bhattacharya, T, Lo, C, Giorgi, E, Hraber, P, ...

No abstract available.

P04-08. Monoclonal antibodies from patient with acute HIV-1 infection (2009)

Chen, W, Xiao, X, Streaker, E, Wang, Y, Markowitz, M, Haynes, B

No abstract available.

P10-05. Suppression of human dendritic cell function during acute HIV infection (2009)

Frleta, D, O'Brien, M, Haynes, B, Kessler, B, Bhardwaj, N

No abstract available.

P01-01. The blood transcriptional response to early acute HIV infection is transient and responsive to antiretroviral therapy (2009)

Skinner, JA, Sharma, M, Baldwin, N, Lemoine, B, Blankenship, D, De Vol, EB, ...

No abstract available.

OA021-04. HIV-1 gp41 envelope MPER mutation altered epitope conformation in lipid and increased sensitivity to 2F5 and 4E10 neutralizing antibodies (2009)

Shen, X, Dennison, M, Gao, F, Montefiori, DC, Verkoczy, L, Haynes, B, ...

No abstract available.

Qualitative organic analysis (1961)

Haynes, B.

The influence of CGS 16949A on peripheral aromatisation in breast cancer patients.

Lønning, P. E., Jacobs, S., Jones, A., Haynes, B., Powles, T., Dowsett, M.

The influence of a new aromatase inhibitor, CGS 16949A on peripheral aromatisation of androstenedione into oestrone was investigated in postmenopausal women with breast cancer. A mixture of 3H...

Endocrine, pharmacokinetic and clinical studies of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione ('pyridoglutethimide') in postmenopausal breast cancer patients.

Dowsett, M., MacNeill, F., Mehta, A., Newton, C., Haynes, B., Jones, A., ...

The aromatase inhibitor, 'pyridoglutethimide' (PyG), has been shown previously to suppress serum oestrogen levels in postmenopausal breast cancer patients and to achieve clinical responses at a dose...

OA021-04. HIV-1 gp41 envelope MPER mutation altered epitope conformation in lipid and increased sensitivity to 2F5 and 4E10 neutralizing antibodies

Shen, X, Dennison, M, Gao, F, Montefiori, DC, Verkoczy, L, Haynes, B, ...

P01-01. The blood transcriptional response to early acute HIV infection is transient and responsive to antiretroviral therapy

Skinner, JA, Sharma, M, Baldwin, N, Lemoine, B, Blankenship, D, De Vol, EB, ...

P10-05. Suppression of human dendritic cell function during acute HIV infection

Frleta, D, O'Brien, M, Haynes, B, Kessler, B, Bhardwaj, N

P04-08. Monoclonal antibodies from patient with acute HIV-1 infection

Chen, W, Xiao, X, Streaker, E, Wang, Y, Markowitz, M, Haynes, B

P09-21 LB. Deep sequencing of HIV-1 from acute infection: low initial diversity, and rapid but variable CTL escape

Fischer, W, Keele, B, Bhattacharya, T, Lo, C, Giorgi, E, Hraber, P, ...

P04-45. Characterization of the plasma cell repertoire in acute HIV-1 infection (AHI)

Liao, L, Chen, X, Dixon, A, Munshaw, S, Moody, M, Zhang, R, ...